Pfizer Embraces Biotech-Like Speed To Advance BCMA Bispecific

Phase II Pivotal Trial Under Way For Elranatamab In Multiple Myeloma

 
• By Mandy Jackson
3D Rendering of abstract highway path through digital binary towers in city
Pfizer is advancing its oncology pipeline with biotech-like speed and pharma scale • Source: Shutterstock

More from Strategy

More from Business